A first-in-human phase 1 and pharmacological study of TAS-119, a novel selective Aurora A kinase inhibitor in patients with advanced solid tumours

British Journal of Cancer, Published online: 06 October 2020; doi:10.1038/s41416-020-01100-3A first-in-human phase 1 and pharmacological study of TAS-119, a novel selective Aurora A kinase inhibitor in patients with advanced solid tumours

Source: British Journal of Cancer - October 5, 2020 Category: Cancer & Oncology Authors: Debbie G. J. Robbrecht Juanita Lopez Emiliano Calvo Xiaomin He Hirai Hiroshi Nital Soni Natalie Cook Afshin Dowlati Angelica Fasolo Victor Moreno Ferry A. L. M. Eskens Johann S. de Bono Source Type: research